The retinoblastoma protein regulates pericentric heterochromatin

被引:107
作者
Isaac, CE
Francis, SM
Martens, AL
Julian, LM
Seifried, LA
Erdmann, N
Binné, UK
Harrington, L
Sicinski, P
Bérubé, NG
Dyson, NJ
Dick, FA
机构
[1] Univ Western Ontario, London Reg Canc Program, London, ON, Canada
[2] Univ Western Ontario, Childrens Hlth Res Inst, London, ON, Canada
[3] Univ Western Ontario, Dept Biochem, London, ON, Canada
[4] Campbell Family Inst Breast Canc Res, Toronto, ON, Canada
[5] Gen Hosp Canc Ctr, Charlestown, MA USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1128/MCB.26.9.3659-3671.2006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The retinoblastoma protein (pRb) has been proposed to regulate cell cycle progression in part through its ability to interact with enzymes that modify histone tails and create a repressed chromatin structure. We created a mutation in the murine Rb1 gene that disrupted pRb's ability to interact with these enzymes to determine if it affected cell cycle control. Here, we show that loss of this interaction slows progression through mitosis and causes aneuploidy. Our experiments reveal that while the LXCXE binding site mutation does not disrupt pRb's interaction with the Suv4-20h histone methyltransferases, it dramatically reduces H4-K20 trimethylation in pericentric heterochromatin. Disruption of heterochromatin structure in this chromosomal region leads to centromere fusions, chromosome missegregation, and genomic instability. These results demonstrate the surprising finding that pRb uses the LXCXE binding cleft to control chromatin structure for the regulation of events beyond the G(1)-to-S-phase transition.
引用
收藏
页码:3659 / 3671
页数:13
相关论文
共 60 条
[1]   Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31 [J].
Aagaard, L ;
Laible, G ;
Selenko, P ;
Schmid, M ;
Dorn, R ;
Schotta, G ;
Kuhfittig, S ;
Wolf, A ;
Lebersorger, A ;
Singh, PB ;
Reuter, G ;
Jenuwein, T .
EMBO JOURNAL, 1999, 18 (07) :1923-1938
[2]   DEFICIENCY OF RETINOBLASTOMA PROTEIN LEADS TO INAPPROPRIATE S-PHASE ENTRY, ACTIVATION OF E2F-RESPONSIVE GENES, AND APOPTOSIS [J].
ALMASAN, A ;
YIN, YX ;
KELLY, RE ;
LEE, EYHP ;
BRADLEY, A ;
LI, WW ;
BERTINO, JR ;
WAHL, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5436-5440
[3]  
Aparicio O., 2005, CURRENT PROTOCOLS MO, V21, P31
[4]   Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage [J].
Avni, D ;
Yang, H ;
Martelli, F ;
Hofmann, F ;
ElShamy, WM ;
Ganesan, S ;
Scully, R ;
Livingston, DM .
MOLECULAR CELL, 2003, 12 (03) :735-746
[5]   Histone hypomethylation is an indicator of epigenetic plasticity in quiescent lymphocytes [J].
Baxter, J ;
Sauer, S ;
Peters, A ;
John, R ;
Williams, R ;
Caparros, ML ;
Arney, K ;
Otte, A ;
Jenuwein, T ;
Merkenschlager, M ;
Fisher, AG .
EMBO JOURNAL, 2004, 23 (22) :4462-4472
[6]   Mice with bad ends: mouse models for the study of telomeres and telomerase in cancer and aging [J].
Blasco, MA .
EMBO JOURNAL, 2005, 24 (06) :1095-1103
[7]   Retinoblastoma protein recruits histone deacetylase to repress transcription [J].
Brehm, A ;
Miska, EA ;
McCance, DJ ;
Reid, JL ;
Bannister, AJ ;
Kouzarides, T .
NATURE, 1998, 391 (6667) :597-601
[8]   Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control [J].
Classon, M ;
Salama, S ;
Gorka, C ;
Mulloy, R ;
Braun, P ;
Harlow, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (20) :10820-10825
[9]   Loss of Rb overrides the requirement for ERK activity for cell proliferation [J].
D'Abaco, GM ;
Hooper, S ;
Paterson, H ;
Marshall, CJ .
JOURNAL OF CELL SCIENCE, 2002, 115 (23) :4607-4616
[10]   Ablation of the Retinoblastoma gene family deregulates G1 control causing immortalization and increased cell turnover under growth-restricting conditions [J].
Dannenberg, JH ;
van Rossum, A ;
Schuijff, L ;
Riele, HT .
GENES & DEVELOPMENT, 2000, 14 (23) :3051-3064